● Recruiting

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Condition: Neovascular (Wet) Age-related Macular Degeneration · Sponsor: Skyline Therapeutics

PhaseN/A

Planned participants83

Who can joinAll sexes, 50 Years to no upper limit

Healthy volunteersNo

About this study

This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.

This description comes directly from the study's public registry record.

Talk to the study team

Yongqin Wang · +86 18616737445 · yongqin.wang@skytx.com

Always discuss trial participation with your own doctor first.

Locations (10)

Ophthalmic Consultants of Boston	Boston, Massachusetts, United States	Not Yet Recruiting
Retina Consultants of Texas	Katy, Texas, United States	Not Yet Recruiting
Wagner Macula & Retina Center	Norfolk, Virginia, United States	Not Yet Recruiting
The Second Hospital Of Anhui Medical University	Hefei, Anhui, China	Not Yet Recruiting
Zhejiang Provincial People's Hospital	Hangzhou, Zhejiang, China	Not Yet Recruiting
Eye Hospital, WMU (Zhejiang Eye Hospital)	Wenzhou, Zhejiang, China	Not Yet Recruiting
Beijing Hospital	Beijing, China	Not Yet Recruiting
Peking Union Medical College Hospital	Beijing, China	Recruiting
EYE & ENT Hospital of Fudan University	Shanghai, China	Recruiting
Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine	Shanghai, China	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06346600